GSK3359609 Plus Tremelimumab for the Treatment of Advanced Solid Tumors

Condition:   Neoplasms
Interventions:   Drug: GSK3359609;   Drug: Tremelimumab;   Drug: Docetaxel;   Drug: Paclitaxel;   Drug: Cetuximab
Sponsors:   GlaxoSmithKline;   MedImmune LLC
Not yet recruiting

https://ift.tt/2Ox7onJ